血代谢的变化与败血症的临床结果之间的关联
Xin Li1, Zhongnan Yin2,3, Wei Yan1
1Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing 100191, China.
Emergency medicine international
|June 22, 2023
概括
动态脂质代谢学,特别是溶解脂胆 (LysoPC) 和髓 (SM) 水平,显示出作为败血症预后生物标志物的前景. 这些脂质的变化与免疫反应和患者生存结果相关.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 目前用于败血症的预后生物标志物缺乏足够的灵敏度和特异性.
- 了解败血症对免疫反应和临床结果的影响至关重要.
- 脂质代谢在败血症病理生理学中的作用需要进一步研究.
研究的目的:
- 在败血症患者中研究动态脂质代谢.
- 将脂质样本与败血性免疫反应和临床结果联系起来.
- 为了确定潜在的新型预后生物标志物用于败血症.
主要方法:
- 40名败血症患者的前性队列研究 (败血症3.0标准).
- 在住院1 (D1) 和7 (D7) 日收集的血样本.
- 液体色谱与双重质谱 (LC-MS/MS) 用于脂质分析.
- 对脂质水平与28天生存状态和免疫细胞标记物 (CD3+ T细胞) 的分析.
主要成果:
- 检测到113种脂质;42种是最丰富的.
- 与幸存者相比,未幸存者在D7-D1上表现出显著较低的溶解酸丁胆 (LysoPC) 和甲 (SM) 水平 (p < 0.05).
- D7-D1的LysoPC水平与CD3+T细胞的百分比呈正相关性.
结论:
- 血LysoPC和SM水平的变化可以作为败血症的预后生物标志物.
- 动态脂质新陈代谢的改变与败血症中的免疫障碍有关.
- 对脂管学的进一步研究可以改善败血症预后和管理.
相关概念视频
Acute Kidney Injury III: Clinical Manifestations
44
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
44
Acute Kidney Injury II: Pathophysiology
37
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
37
Acute Kidney Injury IV: Diagnostic Studies and Prevention
40
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
40
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
127
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
204
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
204
Chronic Kidney Disease II: Clinical Manifestations
40
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
40


